Etzer Darout
Stock Analyst at BMO Capital
(0.89)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TERN Terns Pharma | Maintains: Outperform | 26 15 | 3.83 | 291.64% | 5 | May 13, 2025 | |
VERV Verve Therapeutics | Maintains: Strong Buy | 18 24 | 11.3 | 112.39% | 2 | Apr 15, 2025 | |
IVA Inventiva | Maintains: Buy | 12 9 | 3.05 | 195.08% | 3 | Apr 4, 2025 | |
ARVN Arvinas | Maintains: Outperform | 82 20 | 7.53 | 165.6% | 4 | Mar 12, 2025 | |
PTGX Protagonist Therapeu... | Reiterates: Outperform | 62 72 | 55.71 | 29.24% | 2 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 130 143 | 106.77 | 33.93% | 4 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 91 96 | 52.94 | 81.34% | 6 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 22 3 | 1.51 | 98.68% | 3 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 21 2 | 1.13 | 76.99% | 2 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 36 40 | 43.67 | -8.4% | 3 | Dec 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 16.55 | 202.11% | 1 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 35 | 11.64 | 200.69% | 1 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 55 | 44.15 | 24.58% | 1 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 63 | 5.47 | 1051.74% | 1 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 27 | 1.21 | 2131.4% | 7 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 132 134 | 79.64 | 68.26% | 6 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 32 34 | 8.16 | 316.67% | 5 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 48 | 20.52 | 133.92% | 3 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 118 120 | 120.33 | -0.27% | 3 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 34 38 | 35.76 | 6.26% | 3 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 26 25 | 4.74 | 427.43% | 6 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 8 5 | 1.21 | 313.22% | 9 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 20 20 | 1.43 | 1298.6% | 3 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 7 6 | 1.03 | 482.52% | 7 | May 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 4 4 | 2.27 | 58.15% | 10 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 82 | 69.89 | 17.33% | 4 | Apr 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 31 | n/a | n/a | 4 | Dec 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 19 | 4.8 | 295.83% | 2 | Apr 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 179 229 | n/a | n/a | 4 | Mar 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 170 | 322.64 | -47.31% | 2 | Feb 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 60 | n/a | n/a | 1 | May 18, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 38 | n/a | n/a | 5 | Mar 9, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 54 | 56.13 | -3.79% | 1 | Feb 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Sep 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 38 | 51.02 | -25.52% | 2 | Sep 9, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 54 52 | 1.45 | 3486.21% | 1 | Mar 28, 2018 |